Printer-friendly version

HIV in the News

Published on: March 27, 2015
From AIDSinfo
"On March 23, 2015, FDA approved revisions to the Epivir (lamivudine) and Ziagen (abacavir sulfate) labels to each provide for once-daily dosing in pediatric patients 3 months of age and older in combination with other antiretroviral agents for the treatment of HIV-1 infection."   The updated labeling for both drugs will be available soon at the FDA website.   More information is available:  FDA:
Published on: March 27, 2015

HIV-positive people on antiretroviral treatment have a low overall risk of death following surgery, but it is still higher on average than those without the virus, in particular if CD4 counts are low.

Published on: March 26, 2015

HIV launches an immediate assault on the gut after infection, spurring inflammation and causing other damage that even very early antiretroviral treatment may not fully reverse.

Published on: March 25, 2015

A so-called TLR7 agonist has shown promise in its ability to wake infected cells from a dormant, or latent, state and cause them to produce HIV.

Published on: March 24, 2015

People with HIV who start treatment with Truvada post similar fat gains whether they pair the tablet with Isentress or protease inhibitors.

Published on: March 23, 2015

Nine people taking Harvoni or Sovaldi and the heart medication Cordarone (amiodarone) have suffered from low heartbeats; one died of a heart attack.

Published on: March 23, 2015

The herpes drug Valtrex suppressed HIV in a small trial, raising the possibility it may one day be added to the HIV antiretroviral portfolio.

Published on: March 21, 2015

New research underscores the great potential of Truvada as pre-exposure prophylaxis for preventing HIV among gay and bisexual men.

Published on: March 20, 2015

The smoking cessation aid Chantix works about as well among people with HIV as those without, although less than a fifth of those taking the drug in a recent trial actually quit smoking.

Published on: March 19, 2015

The proportion of poor African-American women accessing health care and HIV testing is rising in high AIDS prevalence areas.

Funded by the US Department of Health & Human Services, the National Institutes of Health,
the National Institute of Allergy and Infectious Diseases, and the Division of AIDS.